Wilex recommends shareholders not accept dievini Hopp offer

Friday 30 July 2010

The management of Wilex AG is asking shareholders not to accept an offer for the company from dievini Hopp BioTech holding GmbH. The venture capital firm was obliged to make the offer after its stake in Wilex moved above 30%.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany